| Cod Nacion | Nro Definitivo | Des Nomco | Des Prese | Cod Vtm | Cod Vmp | Cod Vmpp | Des Dosific | Cod Forfar | Cod Forfar Simplificada | Cod Envase | Contenido | Unid Contenido | Nro Conte | Cod Atc | Sw Psicotropo | Sw Estupefaciente | Sw Afecta Conduccion | Sw Triangulo Negro | Url Fictec | Url Prosp | Sw Receta | Sw Generico | Sw Sustituible | Sw Envase Clinico | Sw Uso Hospitalario | Sw Diagnostico Hospitalario | Sw Tld | Sw Especial Control Medico | Sw Huerfano | Sw Base A Plantas | Laboratorio Titular | Laboratorio Comercializador | Fecha Autorizacion | Sw Comercializado | Cod Sitreg | Cod Sitreg Presen | Fecha Situacion Registro | Fec Sitreg Presen | Sw Tiene Excipientes Decl Obligatoria | Nro Pactiv | Fec Comer | Lista Psicotropo | Cod Nacionales Inactivos | Lista Estupefaciente | Hash | Last Modified | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 680708 | 74083 | GEMCITABINA HOSPIRA 200 mg CONCENTRADO PARA SOLUCION PARA PERFUSION | GEMCITABINA HOSPIRA 200 mg CONCENTRADO PARA SOLUCION PARA PERFUSION , 1 vial de 5,3 ml | 200 mg inyectable 5,3 ml | 45 | 1 | 34 | 1 vial de 5,3 ml | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/74083/74083_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/74083/74083_p.pdf | 1 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 11622 | PFIZER S.L. | 2011-08-04 | 1 | 1 | 1 | 2011-08-04 | 2011-08-04 | 1 | 2012-06-14 | View Edit Delete | ||||||||||||
| 678599 | 61155 | DYSPORT 500 U POLVO PARA SOLUCION INYECTABLE | DYSPORT 500 U POLVO PARA SOLUCION INYECTABLE , 2 viales | 500 U | 45 | 2 | 34 | 2 viales | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/61155/61155_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/61155/61155_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 68629 | IPSEN PHARMA S.A.U. | 1997-12-01 | 1 | 1 | 1 | 1997-12-01 | 1997-12-01 | 1 | 2011-10-25 | View Edit Delete | ||||||||||||
| 677039 | 61238 | MAG3 TECHNESCAN 1 mg EQUIPO DE REACTIVOS PARA PREPARACION RADIOFARMACEUTICA | MAG3 TECHNESCAN 1 mg EQUIPO DE REACTIVOS PARA PREPARACION RADIOFARMACEUTICA , 5 viales de 10 ml | 1 mg | 45 | 5 | 34 | 5 viales de 10 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/61238/61238_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/61238/61238_p.pdf | 1 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 28969 | CURIUM PHARMA SPAIN S.A. | 1998-07-01 | 1 | 1 | 1 | 1998-07-01 | 1998-07-01 | 1 | 2011-10-05 | View Edit Delete | ||||||||||||
| 677644 | 73797 | DOPACIS 90 MBq/ml SOLUCION INYECTABLE | DOPACIS 90 MBq/ml SOLUCION INYECTABLE , 1 vial de 15 ml | 90 MBq/ml | 45 | 1 | 34 | 1 vial de 15 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/73797/73797_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/73797/73797_p.pdf | 1 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 689 | CURIUM PHARMA SPAIN S.A. | 2011-04-05 | 1 | 1 | 1 | 2018-07-19 | 2018-07-19 | 1 | 2012-04-17 | View Edit Delete | ||||||||||||
| 680800 | 74118 | INDIO (111 IN) DTPA CURIUM PHARMA SPAIN 37 MBq/ml SOLUCION INYECTABLE | INDIO (111 IN) DTPA CURIUM PHARMA SPAIN 37 MBq/ml SOLUCION INYECTABLE , 1 vial de 185 MBg en fecha y hora de calibración | 37 MBq/ml | 45 | 1 | 34 | 1 vial de 18,5 MBq en fecha y hora de calibración | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/74118/74118_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/74118/74118_p.pdf | 1 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 28969 | CURIUM PHARMA SPAIN S.A. | 2011-05-25 | 1 | 1 | 1 | 2011-05-25 | 2011-05-25 | 1 | 2011-10-05 | View Edit Delete | ||||||||||||
| 680802 | 74118 | INDIO (111 IN) DTPA CURIUM PHARMA SPAIN 37 MBq/ml SOLUCION INYECTABLE | INDIO (111 IN) DTPA CURIUM PHARMA SPAIN 37 MBq/ml SOLUCION INYECTABLE , 1 vial de 37 MBg en fecha y hora de calibración | 37 MBq/ml | 45 | 1 | 34 | 1 vial de 37 Mqg en fecha y hora de calibración | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/74118/74118_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/74118/74118_p.pdf | 1 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 28969 | CURIUM PHARMA SPAIN S.A. | 2011-05-25 | 1 | 1 | 1 | 2011-05-25 | 2011-05-25 | 1 | 2011-10-05 | View Edit Delete | ||||||||||||
| 676251 | 73010 | PACLITAXEL ACCORD 6 mg/ml CONCENTRADO PARA SOLUCION PARA PERFUSION EFG | PACLITAXEL ACCORD 6 mg/ml CONCENTRADO PARA SOLUCION PARA PERFUSION EFG , 1 vial de 5 ml | 6 mg/ml inyectable 5 ml | 45 | 1 | 34 | 1 vial de 5 ml | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/73010/73010_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/73010/73010_p.pdf | 1 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 11104 | ACCORD HEALTHCARE S.L.U. | 2011-10-27 | 1 | 1 | 1 | 2011-10-27 | 2011-10-27 | 1 | 2012-05-21 | View Edit Delete | ||||||||||||
| 676252 | 73010 | PACLITAXEL ACCORD 6 mg/ml CONCENTRADO PARA SOLUCION PARA PERFUSION EFG | PACLITAXEL ACCORD 6 mg/ml CONCENTRADO PARA SOLUCION PARA PERFUSION EFG , 1 vial de 16,7 ml | 6 mg/ml inyectable 16,7 ml | 45 | 1 | 34 | 1 vial de 16,7 ml | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/73010/73010_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/73010/73010_p.pdf | 1 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 11104 | ACCORD HEALTHCARE S.L.U. | 2011-10-27 | 1 | 1 | 1 | 2011-10-27 | 2011-10-27 | 1 | 2012-05-21 | View Edit Delete | ||||||||||||
| 676253 | 73010 | PACLITAXEL ACCORD 6 mg/ml CONCENTRADO PARA SOLUCION PARA PERFUSION EFG | PACLITAXEL ACCORD 6 mg/ml CONCENTRADO PARA SOLUCION PARA PERFUSION EFG , 1 vial de 50 ml | 6 mg/ml inyectable 50 ml | 45 | 1 | 34 | 1 vial de 50 ml | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/73010/73010_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/73010/73010_p.pdf | 1 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 11104 | ACCORD HEALTHCARE S.L.U. | 2011-10-27 | 1 | 1 | 1 | 2011-10-27 | 2011-10-27 | 1 | 2012-06-13 | View Edit Delete | ||||||||||||
| 677175 | 73266 | DOXORUBICINA ACCORD 2 MG/ML CONCENTRADO PARA SOLUCION PARA PERFUSION EFG | DOXORUBICINA ACCORD 2 MG/ML CONCENTRADO PARA SOLUCION PARA PERFUSION EFG, 1 vial de 5 ml | 2 mg/ml inyectable 5 ml | 45 | 1 | 34 | 1 vial de 5 ml | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/73266/73266_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/73266/73266_p.pdf | 1 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 11104 | ACCORD HEALTHCARE S.L.U. | 2011-07-04 | 1 | 1 | 1 | 2011-07-04 | 2011-07-04 | 1 | 2012-03-05 | View Edit Delete | ||||||||||||
| 677176 | 73266 | DOXORUBICINA ACCORD 2 MG/ML CONCENTRADO PARA SOLUCION PARA PERFUSION EFG | DOXORUBICINA ACCORD 2 MG/ML CONCENTRADO PARA SOLUCION PARA PERFUSION EFG, 1 vial de 25 ml | 2 mg/ml inyectable 25 ml | 45 | 1 | 34 | 1 vial de 25 ml | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/73266/73266_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/73266/73266_p.pdf | 1 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 11104 | ACCORD HEALTHCARE S.L.U. | 2011-07-04 | 1 | 1 | 1 | 2011-07-04 | 2011-07-04 | 1 | 2012-03-07 | View Edit Delete | ||||||||||||
| 677177 | 73266 | DOXORUBICINA ACCORD 2 MG/ML CONCENTRADO PARA SOLUCION PARA PERFUSION EFG | DOXORUBICINA ACCORD 2 MG/ML CONCENTRADO PARA SOLUCION PARA PERFUSION EFG, 1 vial de 100 ml | 2 mg/ml inyectable 100 ml | 45 | 1 | 34 | 1 vial de 100 ml | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/73266/73266_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/73266/73266_p.pdf | 1 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 11104 | ACCORD HEALTHCARE S.L.U. | 2011-07-04 | 1 | 1 | 1 | 2011-07-04 | 2011-07-04 | 1 | 2012-03-07 | View Edit Delete | ||||||||||||
| 679568 | 70707 | CARBOPLATINO ACCORD 10 mg/ml CONCENTRADO PARA SOLUCION PARA PERFUSION EFG | CARBOPLATINO ACCORD 10 mg/ml CONCENTRADO PARA SOLUCION PARA PERFUSION EFG, 1 vial de 60 ml | 10 mg/ml inyectable 60 ml | 45 | 1 | 34 | 1 vial de 60 ml | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/70707/70707_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/70707/70707_p.pdf | 1 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 11104 | ACCORD HEALTHCARE S.L.U. | 2011-04-13 | 1 | 1 | 1 | 2011-04-13 | 2011-04-13 | 0 | 2012-07-04 | View Edit Delete | ||||||||||||
| 679927 | 73962 | AZITROMICINA ALTAN 500 mg POLVO PARA SOLUCION PARA PERFUSION EFG | AZITROMICINA ALTAN 500 mg POLVO PARA SOLUCION PARA PERFUSION EFG , 1 vial | 500 mg | 45 | 1 | 34 | 1 vial | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/73962/73962_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/73962/73962_p.pdf | 1 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 41609 | ALTAN PHARMACEUTICALS S.A. | 2011-04-27 | 1 | 1 | 1 | 2011-04-27 | 2011-04-27 | 1 | 2011-11-15 | View Edit Delete | ||||||||||||
| 677726 | 11688001 | CINRYZE 500 UNIDADES POLVO Y DISOLVENTE PARA SOLUCION INYECTABLE | CINRYZE 500 UNIDADES POLVO Y DISOLVENTE PARA SOLUCION INYECTABLE, 2 viales + 2 viales de disolvente | 500 UI | 45 | 2 | 34 | 2 viales + 2 viales de disolvente | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/11688001/11688001_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/11688001/11688001_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 32558 | TAKEDA FARMACEUTICA ESPANA S.A. | 2011-08-01 | 1 | 1 | 1 | 2011-08-01 | 2011-08-01 | 1 | 2012-09-10 | View Edit Delete | ||||||||||||
| 677730 | 11687002 | HIZENTRA 200 MG/ML SOLUCIÓN INYECTABLE SUBCUTÁNEA | HIZENTRA 200 MG/ML SOLUCIÓN INYECTABLE SUBCUTÁNEA, 10 viales de 5 ml | 200 mg/ml inyectable 5 ml | 45 | 10 | 34 | 10 viales de 5 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/11687002/11687002_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/11687002/11687002_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 27753 | CSL BEHRING S.A. | 2011-08-04 | 1 | 1 | 1 | 2011-08-04 | 2011-08-04 | 1 | 2012-07-31 | View Edit Delete | ||||||||||||
| 677734 | 11687005 | HIZENTRA 200 MG/ML SOLUCIÓN INYECTABLE SUBCUTÁNEA | HIZENTRA 200 MG/ML SOLUCIÓN INYECTABLE SUBCUTÁNEA, 10 viales de 10 ml | 200 mg/ml inyectable 10 ml | 45 | 10 | 34 | 10 viales de 10 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/11687005/11687005_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/11687005/11687005_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 27753 | CSL BEHRING S.A. | 2011-08-04 | 1 | 1 | 1 | 2011-08-04 | 2011-08-04 | 1 | 2023-11-20 | View Edit Delete | ||||||||||||
| 677742 | 11687012 | HIZENTRA 200 MG/ML SOLUCION INYECTABLE SUBCUTANEA | HIZENTRA 200 MG/ML SOLUCION INYECTABLE SUBCUTANEA, 20 viales de 20 ml | 4 g inyectable 20 ml | 45 | 20 | 34 | 20 viales de 20 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/11687012/11687012_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/11687012/11687012_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 27753 | CSL BEHRING S.A. | 2011-08-04 | 1 | 1 | 1 | 2011-08-04 | 2011-08-04 | 1 | 2023-11-20 | View Edit Delete | ||||||||||||
| 679076 | 61117 | AMBISOME LIPOSOMAL 50 MG POLVO PARA DISPERSION PARA PERFUSION | AMBISOME LIPOSOMAL 50 MG POLVO PARA DISPERSION PARA PERFUSION , 10 viales | 50 mg | 45 | 10 | 34 | 10 viales | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/61117/61117_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/61117/61117_p.pdf | 1 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 88172 | GILEAD SCIENCES S.L. | 1996-04-01 | 1 | 1 | 1 | 1996-04-01 | 1996-04-01 | 1 | 2012-01-02 | View Edit Delete | ||||||||||||
| 680507 | 74067 | XEOMIN 50 UNIDADES POLVO PARA SOLUCION INYECTABLE | XEOMIN 50 UNIDADES POLVO PARA SOLUCION INYECTABLE , 2 viales | 50 U | 45 | 2 | 34 | 2 viales | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/74067/74067_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/74067/74067_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 1839 | MERZ THERAPEUTICS IBERIA S.L.U. | 2012-03-16 | 1 | 1 | 1 | 2012-03-16 | 2012-03-16 | 1 | 2013-01-15 | View Edit Delete |
Page 291 of 1036, showing 20 records out of 20716 total, starting on record 5801, ending on 5820